• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by British American Tobacco Industries p.l.c.

    5/6/26 11:06:14 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $BTI alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    BRITISH AMERICAN TOBACCO PLC

    (Name of Issuer)


    COMMON STOCK

    (Title of Class of Securities)




    G1510J102

    (CUSIP Number)
    03/31/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    G1510J102


    1Names of Reporting Persons

    FMR LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    109,894,891.63
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    123,159,168.99
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    123,159,168.99
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.7 %
    12Type of Reporting Person (See Instructions)

    HC


    SCHEDULE 13G

    CUSIP Number(s):
    G1510J102


    1Names of Reporting Persons

    Abigail P. Johnson
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    123,159,168.99
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    123,159,168.99
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.7 %
    12Type of Reporting Person (See Instructions)

    IN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    BRITISH AMERICAN TOBACCO PLC
    (b)Address of issuer's principal executive offices:

    GLOBE HOUSE,4 TEMPLE PLACE,London,X0,WC2R 2PG
    Item 2. 
    (a)Name of person filing:

    FMR LLC
    (b)Address or principal business office or, if none, residence:

    245 Summer Street, Boston, Massachusetts 02210
    (c)Citizenship:

    Not applicable
    (d)Title of class of securities:

    COMMON STOCK
    (e)CUSIP Number(s):

    G1510J102
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    123159168.99
    (b)Percent of class:

    5.7  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    Please see the responses to Items 5 and 6 on the cover page.

     (ii) Shared power to vote or to direct the vote:

    0.00

     (iii) Sole power to dispose or to direct the disposition of:

    123159168.99

     (iv) Shared power to dispose or to direct the disposition of:

    0.00

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of BRITISH AMERICAN TOBACCO PLC. No one other person's interest in the COMMON STOCK of BRITISH AMERICAN TOBACCO PLC is more than five percent of the total outstanding COMMON STOCK.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.


    See attached Exhibit 99.
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    FMR LLC
     
    Signature:Richard Bourgelas
    Name/Title:Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
    Date:05/05/2026
     
    Abigail P. Johnson
     
    Signature:Richard Bourgelas
    Name/Title:Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of Abigail P. Johnson*
    Date:05/05/2026

    Comments accompanying signature:  *This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on April 29,2026, accession number: 0000315066-26-000738.
    Exhibit Information

    Please see Exhibit 99 for 13d-1(k) (1) agreement.

    Get the next $BTI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BTI

    DatePrice TargetRatingAnalyst
    12/12/2025Buy
    Kepler
    9/8/2025$62.00Hold → Buy
    Argus
    9/2/2025Sector Perform → Underperform
    RBC Capital Mkts
    7/9/2025Buy
    Jefferies
    4/30/2025Buy
    BofA Securities
    1/27/2025Neutral → Buy
    UBS
    10/3/2024$33.00Overweight → Underweight
    Morgan Stanley
    1/23/2024Neutral
    UBS
    More analyst ratings

    $BTI
    SEC Filings

    View All

    SEC Form 6-K filed by British American Tobacco Industries p.l.c.

    6-K - British American Tobacco p.l.c. (0001303523) (Filer)

    6/5/26 11:02:41 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by British American Tobacco Industries p.l.c.

    6-K - British American Tobacco p.l.c. (0001303523) (Filer)

    6/4/26 11:56:20 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by British American Tobacco Industries p.l.c.

    6-K - British American Tobacco p.l.c. (0001303523) (Filer)

    6/2/26 4:33:26 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Kepler initiated coverage on British American Tobacco

    Kepler initiated coverage of British American Tobacco with a rating of Buy

    12/12/25 8:49:35 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    British American Tobacco upgraded by Argus with a new price target

    Argus upgraded British American Tobacco from Hold to Buy and set a new price target of $62.00

    9/8/25 8:36:41 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    British American Tobacco downgraded by RBC Capital Mkts

    RBC Capital Mkts downgraded British American Tobacco from Sector Perform to Underperform

    9/2/25 8:32:33 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Bt De Investments Inc. converted options into 95,281,277 shares and was granted 14,662,765 shares (SEC Form 4)

    4 - British American Tobacco p.l.c. (0001303523) (Reporting)

    5/29/26 4:30:34 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 3 filed by new insider Bt De Investments Inc.

    3 - British American Tobacco p.l.c. (0001303523) (Reporting)

    11/23/22 4:29:54 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results

    Anticipated CMMI Medicare Pilot Program Participation, Regulatory Momentum, and Cost Structure Improvements Position Company for Growth and Pathway to ProfitabilityLOUISVILLE, Colo., March 31, 2026 /CNW/ - (TSX:CWEB) (OTC:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter and year ended December 31, 2025. All amounts are expressed in U.S. dollars, unless otherwise stated. SUBSEQUENT MATERIAL EVENTS BA

    3/31/26 7:07:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    Charlotte's Web Announces Transaction with BAT: Debenture Conversion and US$10M Equity Investment to Strengthen Balance Sheet

    Transaction Addresses Capital Structure and Supports Near-Term Operating Priorities, Including Anticipated CMMI Medicare Pilot Program ParticipationLOUISVILLE, Colo., March 30, 2026 /CNW/ - (TSX:CWEB) (OTCQB:CWBHF) Charlotte's Web Holdings, Inc., a botanical wellness innovation company and the market leader in cannabidiol ("CBD") hemp extract wellness products, today announced a transaction with BT DE Investments, Inc. ("BAT"), a subsidiary of British American Tobacco plc (NYSE:BTI), comprising two components: (i) amendment and conversion of BAT's outstanding C$75.3 million principal amount (approximately US$54 million) of the convertible debenture, as well as all accrued interest, into comm

    3/30/26 10:59:00 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    Better-for-You Stimulant Formats Gain Scale as Consumer Demand Reshapes Delivery Landscape

    Issued on behalf of Doseology Sciences Inc.VANCOUVER, BC, March 4, 2026 /CNW/ -- USANewsGroup.com News Commentary -- Consumer habits continue to shift, and there's no better example to point at than the rise of pouches. The global oral nicotine pouch market is projected to surge from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR[1]. On top of this, consumer habits are shifting toward tobacco-free formats which are accelerating alongside demand for functional, portable energy delivery systems that eliminate liquid bulk and sugar crashes[2]. This convergence is channeling capital toward consumer goods platforms built around precise dosing, clean ingredients, and mod

    3/4/26 11:51:00 AM ET
    $BTI
    $CELH
    $KDP
    Medicinal Chemicals and Botanical Products
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples

    $BTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

    SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

    2/9/24 6:03:23 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

    SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

    2/9/24 5:46:32 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

    SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

    1/26/24 4:56:06 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    Leadership Updates

    Live Leadership Updates

    View All

    Charlotte's Web Appoints M. Borgia Walker to Board of Directors

    Accomplished Executive Brings Three Decades of Transformation and Financial Leadership Experience from Global Consumer Goods and Financial Services Industries LOUISVILLE, Colo., Oct. 21, 2025 /PRNewswire/ - (TSX:CWEB) (OTCQB:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, is pleased to announce the appointment of M. Borgia Walker to its Board of Directors, effective November 1, 2025. Ms. Walker brings extensive global leadership experie

    10/21/25 8:15:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    British American Tobacco p.l.c investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2024 deadline

    Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises British American Tobacco p.l.c (NYSE:BTI) investors that a lawsuit was filed on behalf of investors that purchased BTI securities between February 9, 2023 and December 6, 2023, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing cla

    1/24/24 6:21:08 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    Charlotte's Web Announces Appointment of Bill Morachnick as Chief Executive Officer

    Provides Update on Majority Voting Policy Process LOUISVILLE, Colo., Sept. 13, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce the appointment of William (Bill) Morachnick who has joined the Company as its Chief Executive Officer. Mr. Morachnick has also been appointed to the Company's Board of Directors as a non-independent director. He replaces CEO Jacques Tortoroli who has elected to resign from his roles at Charlotte's Web.  CWEB) (OTCQX:CWBHF):. The World's Most Trusted Hemp Extract and Official CBD of Major League Baseball (MLB). (C

    9/13/23 7:07:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    Financials

    Live finance-specific insights

    View All

    Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results

    Anticipated CMMI Medicare Pilot Program Participation, Regulatory Momentum, and Cost Structure Improvements Position Company for Growth and Pathway to ProfitabilityLOUISVILLE, Colo., March 31, 2026 /CNW/ - (TSX:CWEB) (OTC:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter and year ended December 31, 2025. All amounts are expressed in U.S. dollars, unless otherwise stated. SUBSEQUENT MATERIAL EVENTS BA

    3/31/26 7:07:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    Charlotte's Web Reports 2024 First Quarter Financial Results

    LOUISVILLE, Colo., May 8, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2024. "The first quarter of 2024 started slowly in terms of sales volume. This is being addressed with solid progress in our 'True North' turnaround initiatives," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "For example, our legacy e-commerce platform limits our ability to be agile

    5/8/24 7:07:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    Charlotte's Web Reports 2023 Second Quarter Financial Results

    Encouraging CBD regulatory progress in CongressNet revenue of $16.0M vs. $18.9M YoYCash increased to $61.7M LOUISVILLE, Colo., Aug. 10, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the second quarter ended June 30, 2023.  Regulatory Update During the second quarter, the U.S. Food and Drug Administration ("FDA") committed to "work at speed" with Congress to resolve a regulatory pathway for hemp-derived CBD.

    8/10/23 7:33:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care